NASUS PHARMA LTD (NSRX) Earnings History & Surprises

NYSEARCA:NSRX • IL0012181553

Current stock price

2.35 USD
-0.2 (-7.84%)
At close:
2.3404 USD
-0.01 (-0.41%)
After Hours:

NSRX Earnings overview

Past quarterly earnings results for NASUS PHARMA LTD (NSRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A
Period
Q1 / 2025
EPS Estimate
-$0.04
Revenue Estimate

Last Reported

Most Recent
Release Date
N/A
Period
Q4 / 2024
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2024 - - - -
Q2 2024 - - - -
Q4 2023 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

NSRX Overview NSRX Technical Analysis Report NSRX Fundamental Analysis Report NSRX Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

NASUS PHARMA LTD / NSRX Earnings FAQ

Did NASUS PHARMA LTD (NSRX) beat earnings estimates last quarter?

NASUS PHARMA LTD (NSRX) missed EPS estimates and missed revenue estimates in the most recent quarter.